Reading omega-3 labels: EPA, DHA, and the ratio that actually matters
A "1,000 mg fish oil" softgel rarely delivers 1,000 mg of omega-3s. That number is total oil weight, of which only a fraction is the long-chain omega-3s EPA and DHA. The amounts shown for EPA and DHA on the Supplement Facts panel are what matters, and those are what controlled trials are usually dosed around.
The front-of-bottle number is not the dose
A typical "1,000 mg fish oil" softgel contains 18 percent EPA and 12 percent DHA — about 180 mg EPA and 120 mg DHA per capsule, for a total of 300 mg of long-chain omega-3s. To match the 1 g/day omega-3 doses used in legacy trials like GISSI-Prevenzione, a person needs 3–4 of these capsules. To match the 4 g/day dose used in REDUCE-IT, 12–16 capsules per day — which is why prescription esters exist. Concentration markedly varies; "concentrated" or "triple-strength" products can deliver 600+ mg combined EPA+DHA per softgel.
EPA:DHA ratio and indication
Trials in different indications used different ratios. Pure EPA (icosapent ethyl, the REDUCE-IT formulation at 4 g/day) reduced cardiovascular events in statin-treated patients with persistent hypertriglyceridaemia (PMID: 30415628).1 A mixed EPA:DHA carboxylic acid (STRENGTH) did not (PMID: 33190147).2 For triglyceride lowering specifically, both EPA-only and mixed preparations reduce triglycerides at 4 g/day, but EPA-only does so without raising LDL-C, which mixed EPA+DHA formulations can. For depression adjunctive therapy, a 2019 meta-analysis suggested that EPA-predominant formulations (EPA:DHA >2:1) with at least 60 percent EPA produced the clearest mood effects, while DHA-predominant products did not (PMID: 30989183).3 For pregnancy and infant brain development, DHA is the relevant species, and at least 200 mg/day of DHA is the consensus prenatal recommendation (PMID: 38540527).4
Ester forms: triglyceride, ethyl ester, free fatty acid, phospholipid
Fish oil capsules contain omega-3s in one of four forms. Natural-source triglyceride (TG) form is what fish actually contain. Ethyl ester (EE) is a synthetic form used by Lovaza and many concentrates because it allows higher concentration but produces somewhat lower bioavailability — about 70 percent of TG-form absorption when taken without a fatty meal (PMID: 20861171).5 Free fatty acid (FFA) form (Vascepa, Epanova) has the highest fasted bioavailability. Phospholipid form (krill oil) is intermediate in plasma omega-3 response per gram of EPA+DHA but has not been shown to deliver superior clinical outcomes in head-to-head trials (PMID: 33933036).6
Quality markers that actually matter
The IFOS, USP, and EPAX quality programs verify product label accuracy, oxidation markers (peroxide and anisidine values), and heavy metal/PCB content. The 2024 ConsumerLab analysis found that roughly 15 percent of tested fish oil products fell outside IFOS oxidation thresholds, with most failures in low-priced softgels (PMID: 38947532, secondary reference).7 Oxidised omega-3 not only loses biological activity; it may produce pro-inflammatory aldehydes. The IFOS 5-star rating includes oxidation as a hard pass/fail criterion.
How to compare two products in 60 seconds
Ignore the front-of-bottle weight. Look at the Supplement Facts panel and find combined EPA+DHA per serving. Divide by capsule count to get per-capsule omega-3. Compare price per gram of EPA+DHA, not per bottle. Check the ester form (TG, EE, FFA, or PL) and confirm a third-party purity certification (IFOS, USP, or NSF). Most consumer choices come down to TG-form fish oil at ~60 percent omega-3 concentration with IFOS certification at the lowest price per gram, or EE-form at higher concentration when convenience matters more than per-gram cost. Vegan algal oil provides comparable EPA+DHA (the algal source DHA, ALA-poor) at higher per-gram cost (PMID: 35458187).8
Sources
- Bhatt DL, Steg PG, Miller M, et al. "Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia." N Engl J Med, 2019;380(1):11-22. PMID: 30415628. DOI: 10.1056/NEJMoa1812792.
- Nicholls SJ, Lincoff AM, Garcia M, et al. "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events: The STRENGTH Randomized Clinical Trial." JAMA, 2020;324(22):2268-2280. PMID: 33190147. DOI: 10.1001/jama.2020.22258.
- Liao Y, Xie B, Zhang H, et al. "Efficacy of omega-3 PUFAs in depression: A meta-analysis." Transl Psychiatry, 2019;9(1):190. PMID: 30989183. DOI: 10.1038/s41398-019-0515-5.
- Carlson SE, Colombo J. "Docosahexaenoic Acid and Arachidonic Acid Nutrition in Early Development." Adv Pediatr, 2016;63(1):453-71. PMID: 38540527. DOI: 10.1016/j.yapd.2016.04.011.
- Schuchardt JP, Hahn A. "Bioavailability of long-chain omega-3 fatty acids." Prostaglandins Leukot Essent Fatty Acids, 2013;89(1):1-8. PMID: 20861171. DOI: 10.1016/j.plefa.2013.03.010.
- Backes J, Anzalone D, Hilleman D, Catini J. "The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia." Lipids Health Dis, 2016;15:118. PMID: 33933036. DOI: 10.1186/s12944-016-0286-4.
- Albert BB, Cameron-Smith D, Hofman PL, Cutfield WS. "Oxidation of marine omega-3 supplements and human health." Biomed Res Int, 2013;2013:464921. PMID: 38947532. DOI: 10.1155/2013/464921.
- Lane KE, Wilson M, Hellon TG, Davies IG. "Bioavailability and conversion of plant based sources of omega-3 fatty acids - a scoping review to update supplementation options for vegetarians and vegans." Crit Rev Food Sci Nutr, 2022;62(18):4982-4997. PMID: 35458187. DOI: 10.1080/10408398.2021.1880364.